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Results  
Methods  
Discussion & Conclusion Background 
Cerebrovascular reactivity (CVR) is a key factor in regulating 
blood flow into the brain, and a marker for vascular disease. If the 
brain's regulatory system is not working, a patient may be in 
serious trouble. Testing of CVR is one method of assessing the 
brain's regulatory capabilities. Transcranial Doppler ultrasound 
(TCD) is one tool to measure CVR. In this method, carbon dioxide 
in the blood is transiently increased (such as with the holding of 
breath), and the resulting blood flow in the brain is measured. In 
this study, we are going to measure the variability of the breath-
holding index. 
Subject(Trial) Mean Blood 
Velocity (cm/s) 
CVR*                            
(s-1) 
Average CVR  
(s-1) 
MAP     
(mmHg) 
1(1) 41.7 2.15 1.86  94 
1(2) 40.3 1.62  - 
1(3) 40.8 1.8  93.33 
2(1) 60 1.9 1.74  83.67 
2(2) 60.2 1.8 -  
2(3) 62.5 1.52 89.33 
3(1) 65 1.8 1.63 89  
3(2) 70 1.5 -  
3(3) 73 1.6 93.33  
4(1) 75 2.4 1.7 99.33  
4(2) 74 1.4 -  
4(3) 76 1.3 91  
Table 1: Mean Blood Velocity (cm/s), CVR (s-1), and mean arterial blood pressure (MAP, mmHg), for 
breath-holding each trial for each of the four subjects. 
Within the four subjects, the standard deviations of the CVR 
measurements are 0.27, 0.20, 0.15, and 0.61 respectively, with an 
overall standard deviation of 0.31 across the population. The 
standard deviation between the average CVR measurements of 
each subject is 0.09. 
The CVR measurement is usually higher after the first breath-
holding for each subject, with the following two CVR 
measurements being lower and less variable. There is no 
significant increase or decrease in the mean arterial blood pressure 
(MAP) before or after breath-holding.  
 
In conclusion, the breath-holding maneuver is a convenient and 
well-tolerated screening method for CVR. However, this 
experiment showed a high variability in this measurement. To 
obtain an accurate result, three breath-holding indices need to be 
taken and averaged for each subject.  
Figure 1: The average blood flow velocity in the MCA (cm/s) during the three breath-holding trials for one 
subject.   
During the data collection sessions in the Biomedical Imaging and 
Biosignal Analysis (BIBA) Laboratory, blood pressure was first 
measured using an automated blood pressure cuff. Then, a gel was 
applied to the transtemporal window of the subject just behind the 
eye and in front of the ear. The TCD was used to measure blood 
flow velocities in the Middle Cerebral Artery (MCA) in the brain. 
This was done by first locating the MCA with a free TCD 
transducer, then utilizing a headband device with the transducer 
attached to obtain a steady measure of the blood flow velocity of 
the subject. A baseline measurement of the blood flow velocity in 
the brain was taken while the subject breathed normally for one 
minute. The subject then was asked to hold their breath halfway 
through an exhale for 30 seconds while the TCD measured the 
blood flow velocity in the MCA, followed by four minutes of 
normal breathing. The process was repeated three times for each 
subject. The subject was then asked to take a full inhale and hold 
for three seconds. The subject’s blood pressure was taken again 
with the automated blood pressure cuff and recorded.  
 
CVR was calculated using the formula: 
 
(𝑉𝑚𝑒𝑎𝑛,𝑏 − 𝑉𝑚𝑒𝑎𝑛,𝑚 )/𝑉(𝑚𝑒𝑎𝑛,𝑏)
𝑡𝑖𝑚𝑒
 
 
Where 𝑉𝑚𝑒𝑎𝑛,𝑏  is the mean blood flow velocity before breath-
holding and 𝑉𝑚𝑒𝑎𝑛,𝑚  is the maximum mean blood flow velocity 
during breath holding, and time is the time where 𝑉𝑚𝑒𝑎𝑛,𝑚  
occurs.  
 
The measurements of CVR were then compared within subjects 
and across the population using standard deviation. This was done 
to determine the variability of CVR between trials of the same 
subject, as well as the variability of CVR across all subjects.  
